Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses

Mostrar todas las versiones(2)

Background: Emerging therapies such as closed-loop (CL) glucose control, also known as artificial pancreas (AP) systems, have shown significant improvement in type 1 diabetes mellitus (T1DM) management. However, demanding patient intervention is still required, particularly at meal times. To reduce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sánchez Peña, Ricardo, Colmegna, Patricio, Garelli, Fabricio, De Battista, Hernán, García Violini, Demián, Moscoso Vásquez, Marcela, Rosales, Nicolás, Fushimi, Emilia, Campos Náñez, Enrique, Breton, Marc, Beruto, Valeria, Scibona, Paula, Rodriguez, Cintia, Giunta, Javier, Simonovich, Ventura, Belloso, Waldo H., Cherñavvsky, Daniel, Grosembacher, Luis
Formato: Articulo
Lenguaje:Inglés
Publicado: 2018
Materias:
Ingeniería
artificial pancreas
carbohydrate counting
clinical trial
sliding mode control
switched control
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/106934
http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6134619&blobtype=pdf
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata

Ejemplares similares

Ejemplares similares